Difficulties of biological therapy in the patient with active rheumatoid arthritis and secondary renal amyloidosis: A report of clinical case

Difficulties of biological therapy in the patient with active rheumatoid arthritis and secondary renal amyloidosis: A report of clinical case

A clinical case of a patient with active rheumatoid arthritis (RA) resistant to standard basic therapy is presented, which served as the reason for the appointment of the target drug – Janus kinase, tofacitinib (Jaquinus) and then biological therapy using anti-IL6 receptor antibody tocilizumab (Acte...

Full description

Bibliographic Details
Main Authors: R. A. Osipyants, M. Z. Kanevskaya, N. L. Kozlovskaya, K. A. Demyanova, M. M. Saidova, A. V. Bespalova, T. Sh. Mirilashvili
Format: Article
Language:Russian
Published: IMA PRESS LLC 2021-05-01
Series:Научно-практическая ревматология
Subjects:
rheumatoid arthritis
aa-amyloidosis
biologics
comorbid infections
Online Access:https://rsp.mediar-press.net/rsp/article/view/3026

Internet

https://rsp.mediar-press.net/rsp/article/view/3026

Similar Items